GSK recalls 600,000 Ventolin Inhalers from US
Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.
The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.
The inhalers, according to reports, have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.
“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”
The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.
About author
You might also like
Reckitt Benckiser partners Zambia on health, hygiene initiatives
Hosts first Healthcare for Women and Children Conference With a focus on heartburn and acid reflux in pregnancy and fever in children, Zambia’s first Healthcare for Women and Children Conference
Ghana renews support to West African Health Organization
Ghanaian Health minister, Hon Kwaku Agyeman Manu, has pledged more support from Ghana to the West African Health Organization (WAHO) to improve health in the West African region. Receiving a
Viagra could reduce risk of heart attack, new study shows
Research shows it can save patients from heart attack Study of 6,000 diabetic patients reveals those taking the pill had less heart incidents than those who didn’t Cuts heart
0 Comments
No Comments Yet!
You can be first to comment this post!